← All compounds

Research use onlyNot for human consumption

Specialized Wellness

PT-141

Melanocortin Receptor Agonist · Sexual Wellness Peptide

PT-141 (bremelanotide) is a synthetic peptide analog that acts as a melanocortin receptor agonist, primarily targeting MC3R and MC4R, and is being researched for its potential to support sexual desire, arousal, and overall sexual wellness through central nervous system pathways.

Trusted Quality
PT-141 vial reference artwork
View one-page graphic ↗

Quick Facts

  • Synthetic peptide analog (bremelanotide)
  • Melanocortin receptor agonist (MC3R and MC4R)
  • Researched for sexual desire, arousal, and libido support
  • Acts centrally in the brain rather than through vascular mechanisms
  • Studied in both men and women
  • Often used in research settings for sexual wellness and desire

Research Highlights

  • Shown to increase sexual desire and arousal in clinical studies
  • Activates melanocortin receptors (MC3R/MC4R) in the central nervous system
  • May enhance sexual motivation and responsiveness
  • Demonstrates effects independent of PDE-5 inhibition or direct vascular action
  • Studied for potential benefits in hypoactive sexual desire and arousal difficulties
  • Generally well tolerated in research settings with a favorable safety profile

How PT-141 Works

Binds to Melanocortin Receptors

PT-141 activates MC3R and MC4R in the central nervous system, influencing neural pathways involved in sexual desire and arousal.

Enhances CNS Signaling

Modulates melanocortin pathways in key brain regions associated with sexual motivation, reward, and arousal behavior.

Supports Desire & Arousal

Helps promote natural sexual desire, arousal, and responsiveness through central rather than vascular mechanisms.

Protocol Tips

  • Typically administered subcutaneously
  • May be used on an as-needed basis
  • Allow 1–2 hours for effect in research settings
  • Stay hydrated and follow proper handling procedures
  • Monitor for common side effects (e.g., nausea, flushing)

Cycle Guidance

  • Typically used as needed rather than continuous
  • No fixed cycle length; often administered prior to anticipated activity
  • Assess individual response and tolerability
  • Allow adequate time between doses
  • Use as part of a comprehensive research plan

Ask about available vial sizes and current pricing.